MA44502A - Dérivés d'indole substitués utilisés en tant qu'inhibiteurs de réplication du virus de la dengue - Google Patents
Dérivés d'indole substitués utilisés en tant qu'inhibiteurs de réplication du virus de la dengueInfo
- Publication number
- MA44502A MA44502A MA044502A MA44502A MA44502A MA 44502 A MA44502 A MA 44502A MA 044502 A MA044502 A MA 044502A MA 44502 A MA44502 A MA 44502A MA 44502 A MA44502 A MA 44502A
- Authority
- MA
- Morocco
- Prior art keywords
- substitute
- dengue virus
- virus replication
- indole derivatives
- derivatives used
- Prior art date
Links
- 241000725619 Dengue virus Species 0.000 title 1
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical class C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 title 1
- 229940054051 antipsychotic indole derivative Drugs 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 230000029812 viral genome replication Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/12—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
- C07D491/048—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/572—Five-membered rings
- C07F9/5728—Five-membered rings condensed with carbocyclic rings or carbocyclic ring systems
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Virology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP16163482 | 2016-04-01 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA44502A true MA44502A (fr) | 2019-02-06 |
Family
ID=55650310
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA044502A MA44502A (fr) | 2016-04-01 | 2017-03-31 | Dérivés d'indole substitués utilisés en tant qu'inhibiteurs de réplication du virus de la dengue |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US10730884B2 (fr) |
| EP (1) | EP3436004A1 (fr) |
| JP (2) | JP7007290B2 (fr) |
| KR (1) | KR102359766B1 (fr) |
| CN (1) | CN109069482B (fr) |
| AU (1) | AU2017240076A1 (fr) |
| BR (1) | BR112018068956A2 (fr) |
| CA (1) | CA3013408A1 (fr) |
| CL (1) | CL2018002784A1 (fr) |
| CO (1) | CO2018009996A2 (fr) |
| CR (1) | CR20180494A (fr) |
| EA (1) | EA201892200A1 (fr) |
| EC (1) | ECSP18073264A (fr) |
| IL (1) | IL261947A (fr) |
| MA (1) | MA44502A (fr) |
| MX (1) | MX2018011786A (fr) |
| PH (1) | PH12018502026A1 (fr) |
| SG (1) | SG11201808237UA (fr) |
| SV (1) | SV2018005750A (fr) |
| WO (1) | WO2017167952A1 (fr) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201116559D0 (en) | 2011-09-26 | 2011-11-09 | Univ Leuven Kath | Novel viral replication inhibitors |
| GB201305376D0 (en) | 2013-03-25 | 2013-05-08 | Univ Leuven Kath | Novel viral replication inhibitors |
| JOP20160086B1 (ar) | 2015-05-08 | 2021-08-17 | 2 Katholieke Univ Leuven Ku Leuven Research And Development | مشتقات اندول مستبدلة احاديا او ثنائيا بصفتها مانعات للتكاثر الفيروسي لحمى الفنك |
| JOP20160198B1 (ar) | 2015-09-16 | 2022-03-14 | Janssen Pharmaceuticals Inc | مشتقات اندول مستبدلة احاديا او ثنائيا بصفتها مانعات للتكاثر الفيروسي لحمى الفنك |
| JO3633B1 (ar) | 2015-09-16 | 2020-08-27 | Katholieke Univ Leuven Ku Leuven Research & Development | مشتقات اندول مستبدلة احاديا او ثنائيا بصفتها مانعات للتكاثر الفيروسي لحمى الفنك |
| CR20180496A (es) | 2016-03-31 | 2018-12-06 | Univ Leuven Kath | Derivados de indolina sustituidos como inhibidores de la replicación vírica de dengue |
| WO2017167950A1 (fr) | 2016-03-31 | 2017-10-05 | Janssen Pharmaceuticals, Inc. | Dérivés d'indole substitués utilisés en tant qu'inhibiteurs de la réplication du virus de la dengue |
| JOP20170069B1 (ar) | 2016-04-01 | 2021-08-17 | 1 Janssen Pharmaceuticals Inc | مشتقات اندولين مستبدلة بصفتها مانعات للتكاثر الفيروسي لحمى الفنك |
| US10730884B2 (en) | 2016-04-01 | 2020-08-04 | Janssen Pharmaceuticals, Inc. | Substituted indole compound derivatives as dengue viral replication inhibitors |
| JOP20180025B1 (ar) | 2017-03-31 | 2021-08-17 | Janssen Pharmaceuticals Inc | مشتقات اندولين مستبدلة بصفتها مانعات للتكاثر الفيروسي لحمى الفنك |
| JOP20180026A1 (ar) | 2017-03-31 | 2019-01-30 | Univ Leuven Kath | مشتقات اندولين مستبدلة بصفتها مانعات للتكاثر الفيروسي لحمى الفنك |
| BR112019024311A2 (pt) | 2017-05-22 | 2020-07-28 | Janssen Pharmaceuticals, Inc. | derivados de indolina substituídos como inibidores da replicação viral do dengue |
| WO2018215315A1 (fr) | 2017-05-22 | 2018-11-29 | Janssen Pharmaceuticals, Inc. | Dérivés d'indoline substitués utilisés en tant qu'inhibiteurs de réplication du virus de la dengue |
| CN108586404A (zh) * | 2018-06-12 | 2018-09-28 | 湖南大学 | 一种n-芳基萘并呋喃酮亚胺类化合物的合成方法 |
| CN108947948B (zh) * | 2018-06-12 | 2021-07-20 | 湖南大学 | 一种n-芳基萘并呋喃酮亚胺类化合物及其合成方法 |
Family Cites Families (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0110832D0 (en) | 2001-05-03 | 2001-06-27 | Virogen Ltd | Antiviral compounds |
| WO2003050295A2 (fr) | 2001-12-12 | 2003-06-19 | Conforma Therapeutics Corporation | Essais et mises en oeuvre permettant de determiner et de moduler une activite de liaison hsp90 |
| GB0215293D0 (en) | 2002-07-03 | 2002-08-14 | Rega Foundation | Viral inhibitors |
| EP1799218A1 (fr) * | 2004-09-30 | 2007-06-27 | Tibotec Pharmaceuticals Ltd. | Pyrimidines bicycliques inhibant le vhc |
| CN101103026A (zh) | 2005-01-14 | 2008-01-09 | 健亚生物科技公司 | 用于治疗病毒感染的吲哚衍生物 |
| CN101304762A (zh) | 2005-02-09 | 2008-11-12 | 米珍尼克斯公司 | 治疗或预防黄病毒科感染的组合物和方法 |
| WO2009039248A2 (fr) * | 2007-09-18 | 2009-03-26 | Stanford University | Méthodes de traitement d'une infection par un virus de la famille des flaviviridae et compositions pour le traitement d'une infection par un virus de la famille des flaviviridae |
| US9029376B2 (en) | 2008-06-03 | 2015-05-12 | Siga Technologies, Inc. | Small molecule inhibitors for the treatment or prevention of dengue virus infection |
| US8143259B2 (en) | 2008-08-19 | 2012-03-27 | Janssen Pharmaceutica, Nv | Cold menthol receptor antagonists |
| GB0910003D0 (en) | 2009-06-11 | 2009-07-22 | Univ Leuven Kath | Novel compounds for the treatment of neurodegenerative diseases |
| US8993604B2 (en) | 2009-06-30 | 2015-03-31 | Siga Technologies, Inc. | Treatment and prevention of dengue virus infections |
| AP2012006413A0 (en) | 2010-01-15 | 2012-08-31 | Gilead Sciences Inc | Inhibitors of flaviviridae viruses |
| GB201116559D0 (en) * | 2011-09-26 | 2011-11-09 | Univ Leuven Kath | Novel viral replication inhibitors |
| GB201305376D0 (en) | 2013-03-25 | 2013-05-08 | Univ Leuven Kath | Novel viral replication inhibitors |
| MX368158B (es) | 2013-10-23 | 2019-09-20 | Janssen Sciences Ireland Uc | Derivados de carboxamida y su uso como medicamentos para el tratamiento de la hepatitis b. |
| CN110845498B (zh) | 2014-01-31 | 2023-02-17 | 百时美施贵宝公司 | 作为因子xia抑制剂的具有杂环p2′基团的大环化合物 |
| JP6701185B2 (ja) * | 2014-10-01 | 2020-05-27 | ヤンセン ファーマシューティカルズ，インコーポレーテッド | デングウィルス複製阻害剤としての一または二置換インドール |
| WO2016050841A1 (fr) * | 2014-10-01 | 2016-04-07 | Janssen Pharmaceuticals, Inc. | Dérivés indole mono ou di-substitués en tant qu'inhibiteurs de la réplication du virus de la dengue |
| NO2721243T3 (fr) | 2014-10-01 | 2018-10-20 | ||
| JOP20150335B1 (ar) | 2015-01-16 | 2022-03-14 | Janssen Pharmaceuticals Inc | مشتقات اندول بصفتها مانعات للتكاثر الفيروسي لحمى الفنك |
| AR103680A1 (es) | 2015-02-23 | 2017-05-24 | Lilly Co Eli | Inhibidores selectivos de bace1 |
| JOP20160086B1 (ar) * | 2015-05-08 | 2021-08-17 | 2 Katholieke Univ Leuven Ku Leuven Research And Development | مشتقات اندول مستبدلة احاديا او ثنائيا بصفتها مانعات للتكاثر الفيروسي لحمى الفنك |
| JO3633B1 (ar) | 2015-09-16 | 2020-08-27 | Katholieke Univ Leuven Ku Leuven Research & Development | مشتقات اندول مستبدلة احاديا او ثنائيا بصفتها مانعات للتكاثر الفيروسي لحمى الفنك |
| JOP20160198B1 (ar) * | 2015-09-16 | 2022-03-14 | Janssen Pharmaceuticals Inc | مشتقات اندول مستبدلة احاديا او ثنائيا بصفتها مانعات للتكاثر الفيروسي لحمى الفنك |
| RU2761212C2 (ru) | 2015-11-03 | 2021-12-06 | Зоэтис Сервисиз Ллс | Полимерные композиты, полученные по способу золь-гель, и их применение |
| WO2017167950A1 (fr) * | 2016-03-31 | 2017-10-05 | Janssen Pharmaceuticals, Inc. | Dérivés d'indole substitués utilisés en tant qu'inhibiteurs de la réplication du virus de la dengue |
| CR20180496A (es) | 2016-03-31 | 2018-12-06 | Univ Leuven Kath | Derivados de indolina sustituidos como inhibidores de la replicación vírica de dengue |
| US10323026B2 (en) | 2016-03-31 | 2019-06-18 | Takeda Pharmaceutical Company Limited | Heterocyclic compound |
| EA039392B1 (ru) | 2016-04-01 | 2022-01-21 | СИГНАЛ ФАРМАСЬЮТИКАЛЗ, ЭлЭлСи | Способ лечения рака с применением замещенного аминопуринового соединения |
| EP3984559A1 (fr) | 2016-04-01 | 2022-04-20 | Kite Pharma, Inc. | Récepteurs antigéniques chimériques et récepteurs de lymphocytes t et leurs procédés d'utilisation |
| JOP20170069B1 (ar) | 2016-04-01 | 2021-08-17 | 1 Janssen Pharmaceuticals Inc | مشتقات اندولين مستبدلة بصفتها مانعات للتكاثر الفيروسي لحمى الفنك |
| RS63735B1 (sr) | 2016-04-01 | 2022-12-30 | Kite Pharma Inc | Himerni receptori i postupci njihove upotrebe |
| SG11201808622SA (en) | 2016-04-01 | 2018-10-30 | Amgen Inc | Chimeric receptors to flt3 and methods of use thereof |
| US10730884B2 (en) | 2016-04-01 | 2020-08-04 | Janssen Pharmaceuticals, Inc. | Substituted indole compound derivatives as dengue viral replication inhibitors |
| KR102411744B1 (ko) | 2016-04-01 | 2022-06-21 | 바스프 에스이 | 바이시클릭 화합물 |
| JOP20180025B1 (ar) | 2017-03-31 | 2021-08-17 | Janssen Pharmaceuticals Inc | مشتقات اندولين مستبدلة بصفتها مانعات للتكاثر الفيروسي لحمى الفنك |
| JOP20180026A1 (ar) | 2017-03-31 | 2019-01-30 | Univ Leuven Kath | مشتقات اندولين مستبدلة بصفتها مانعات للتكاثر الفيروسي لحمى الفنك |
| WO2018215315A1 (fr) | 2017-05-22 | 2018-11-29 | Janssen Pharmaceuticals, Inc. | Dérivés d'indoline substitués utilisés en tant qu'inhibiteurs de réplication du virus de la dengue |
| BR112019024311A2 (pt) | 2017-05-22 | 2020-07-28 | Janssen Pharmaceuticals, Inc. | derivados de indolina substituídos como inibidores da replicação viral do dengue |
-
2017
- 2017-03-31 US US16/088,198 patent/US10730884B2/en active Active
- 2017-03-31 BR BR112018068956A patent/BR112018068956A2/pt not_active Application Discontinuation
- 2017-03-31 AU AU2017240076A patent/AU2017240076A1/en not_active Abandoned
- 2017-03-31 EP EP17714752.7A patent/EP3436004A1/fr active Pending
- 2017-03-31 MA MA044502A patent/MA44502A/fr unknown
- 2017-03-31 JP JP2018549980A patent/JP7007290B2/ja active Active
- 2017-03-31 MX MX2018011786A patent/MX2018011786A/es unknown
- 2017-03-31 CR CR20180494A patent/CR20180494A/es unknown
- 2017-03-31 KR KR1020187027650A patent/KR102359766B1/ko active IP Right Grant
- 2017-03-31 WO PCT/EP2017/057662 patent/WO2017167952A1/fr active Application Filing
- 2017-03-31 CN CN201780022068.1A patent/CN109069482B/zh active Active
- 2017-03-31 CA CA3013408A patent/CA3013408A1/fr not_active Abandoned
- 2017-03-31 EA EA201892200A patent/EA201892200A1/ru unknown
- 2017-03-31 SG SG11201808237UA patent/SG11201808237UA/en unknown
-
2018
- 2018-09-21 PH PH12018502026A patent/PH12018502026A1/en unknown
- 2018-09-21 CO CONC2018/0009996A patent/CO2018009996A2/es unknown
- 2018-09-26 IL IL261947A patent/IL261947A/en unknown
- 2018-09-28 SV SV2018005750A patent/SV2018005750A/es unknown
- 2018-09-28 EC ECSENADI201873264A patent/ECSP18073264A/es unknown
- 2018-09-28 CL CL2018002784A patent/CL2018002784A1/es unknown
-
2021
- 2021-10-15 JP JP2021169228A patent/JP2022009166A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP2019511502A (ja) | 2019-04-25 |
| WO2017167952A1 (fr) | 2017-10-05 |
| CA3013408A1 (fr) | 2017-10-05 |
| ECSP18073264A (es) | 2018-10-31 |
| BR112018068956A2 (pt) | 2019-01-22 |
| JP2022009166A (ja) | 2022-01-14 |
| MX2018011786A (es) | 2019-05-20 |
| SV2018005750A (es) | 2018-11-15 |
| CO2018009996A2 (es) | 2018-09-28 |
| AU2017240076A1 (en) | 2018-08-09 |
| CR20180494A (es) | 2019-01-29 |
| JP7007290B2 (ja) | 2022-01-24 |
| KR20180130502A (ko) | 2018-12-07 |
| CN109069482A (zh) | 2018-12-21 |
| EP3436004A1 (fr) | 2019-02-06 |
| US10730884B2 (en) | 2020-08-04 |
| EA201892200A1 (ru) | 2019-03-29 |
| US20190276467A1 (en) | 2019-09-12 |
| KR102359766B1 (ko) | 2022-02-07 |
| PH12018502026A1 (en) | 2019-02-11 |
| IL261947A (en) | 2018-10-31 |
| CL2018002784A1 (es) | 2018-12-14 |
| CN109069482B (zh) | 2022-04-05 |
| SG11201808237UA (en) | 2018-10-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA44502A (fr) | Dérivés d'indole substitués utilisés en tant qu'inhibiteurs de réplication du virus de la dengue | |
| MA44498A (fr) | Dérivés d'indoline substituée utilisés en tant qu'inhibiteurs de la réplication du virus de la dengue | |
| MA48987A (fr) | Dérivés d'indoline substitués utilisés en tant qu'inhibiteurs de réplication du virus de la dengue | |
| MA48943A (fr) | Dérivés d'indoline substitués utilisés en tant qu'inhibiteurs de réplication du virus de la dengue | |
| MA41341A (fr) | Dérivés indole utilisés en tant qu'inhibiteurs de la réplication du virus de la dengue | |
| MA42810A (fr) | Dérivés d'indole monosubstitués ou disubstitués utilisés en tant qu'inhibiteurs de la réplication du virus de la dengue | |
| MA47125A (fr) | Dérivés de pyrazole en tant qu'inhibiteurs de malt1 | |
| MA45189A (fr) | Nouveaux dérivés hétérocycliques utiles en tant qu'inhibiteurs de shp2 | |
| MA49013A (fr) | Nouveaux dérivés hétérocycliques utiles en tant qu'inhibiteurs de shp2 | |
| MA47123A (fr) | Dérivés de benzooxazole en tant qu'mmunomodulateurs | |
| MA47120A (fr) | Dérivés pyridine utilisés en tant qu'immunomodulateurs | |
| MA46339A (fr) | Dérivés de cyanopyrrolidine ayant une activité en tant qu'inhibiteurs de l'usp 30 | |
| MA45153A (fr) | Dérivés de carbonucléosides substitués utiles en tant qu'agents anticancéreux | |
| MA42659A (fr) | Dérivés hétéroaryle utilisés en tant qu'inhibiteurs de parp | |
| MA45244A (fr) | Pyridines substituées utilisées en tant qu'inhibiteurs de dnmt1 | |
| MA47086A (fr) | Dérivés de dihydropyrimidine-carboxamide bicycliques utilisés en tant qu'inhibiteurs de rho-kinase | |
| MA46981A (fr) | Dérivés de benzimidazole en tant qu'inhibiteurs de bromodomaine | |
| MA41140A (fr) | Dérivés de 2,4-dioxo-quinazoline-6-sulfonamide en tant qu'inhibiteurs de la parg | |
| MA40774A (fr) | Dérivés de diaryle-urée en tant qu'inhibiteurs de kinase p38 | |
| MA46745A (fr) | Dérivés d'indazole en tant qu'antagonistes de l'intégrine alpha v | |
| DK3630724T3 (da) | Substituerede indolinderivater som inhibitorer af virusreplikation af denguevirus | |
| MA47460A (fr) | Aminotriazolopyridines utilisées en tant qu'inhibiteurs de kinase | |
| DK3601266T3 (da) | Substituerede indolinderivater som hæmmere af dengue-virusreplikation | |
| ZA201806482B (en) | Substituted indoline derivatives as dengue viral replication inhibitors | |
| MA51429A (fr) | Dérivés amino-fluoropipéridines utilisés en tant qu'inhibiteur de kinase |